Skip to content

Nuvation Bio NUVB Operating Lease Liabilities

Operating Lease Liabilities at other companies

Immunome logo
ImmunomeIMNM
$3.69M-22.6%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$43.88M-0.8%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$28.25M+10.1%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$33.15M+0.2%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$29.96M-12.2%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$16.86M+480%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's operating lease liabilities?
Nuvation Bio (NUVB) reported operating lease liabilities of $2.2M in Q1 2026.
How has Nuvation Bio's operating lease liabilities changed year-over-year?
Nuvation Bio's operating lease liabilities decreased by 42.7% year-over-year, from $3.84M to $2.2M.
What is the long-term trend for Nuvation Bio's operating lease liabilities?
Over 5 years (2020 to 2025), Nuvation Bio's operating lease liabilities has grown at a -3.9% compound annual growth rate (CAGR), from $3.1M to $2.54M.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.